Dodla margins crushed: consolidated PAT down 35% YoY to ₹41 Cr as milk costs surge
PAT -35.36% YoY · revenue +18.97% · margins compressing
₹1,197.94 Cr
+18.97% YoY
₹40.64 Cr
-35.36% YoY
3.35%
-2.8pp YoY
₹6.74
Dodla Dairy's Q1 FY27 consolidated revenue rose 19.0% YoY to ₹1,197.94 Cr, but net profit fell 35.4% to ₹40.64 Cr (and 41.7% sequentially from ₹69.73 Cr), with net margin compressing to 3.4% from 6.1% a year ago. There were no exceptional items on either side, so raw and adjusted YoY profit growth are identical — the decline is entirely operational. The headline topline is also flattered by consolidation of HR Food Processing (effective Aug 2025), which management itself flags renders the YoY numbers non-comparable; standalone revenue grew just 6.1% to ₹955.66 Cr.
Q1 FY-2027 vs prior quarters
The squeeze sits squarely on the raw-material line: consolidated cost of materials consumed jumped ~32% YoY to ₹940.61 Cr, far outpacing the 19% revenue rise, reflecting elevated milk procurement prices. The pain is starkest in the core standalone India business, where PAT collapsed 65% YoY to ₹21.75 Cr; overseas subsidiaries (₹210.28 Cr revenue, ₹18.23 Cr net profit) plus HR Food cushioned the group figure. That leaves a ~30-point gap between standalone (-65%) and consolidated (-35%) profit trends — readers should note the consolidated print understates how hard domestic dairy was hit.
The stock went into the print at ₹1,070, down 5.6% over the past month of trading.
For context: revenue is at a 6-quarter high.
What the summary numbers don't show
Consolidated EPS ₹6.74 vs ₹10.42 YoY — no exceptional items this quarter (Q4 FY26 had ₹3.21 Cr)
Management projects low to mid-teens revenue growth for FY27, supported by OSAM, continued Africa trajectory, and 8-9% organic growth in India. Gross margins are expected to recover by 50-100 basis points over FY26 due to normalizing procurement costs and pricing actions. Strategic direction focuses on funding growth c
— This quarter: missed
On the Q4 FY26 concall management guided to low-to-mid-teens FY27 revenue growth with a 50-100 bps gross-margin recovery as procurement costs normalized. Q1 delivers the topline (reported +19%, though inorganic; standalone +6% at the low end of the 8-9% organic India target) but decisively misses on margins — procurement costs rose rather than eased, directly contradicting the recovery thesis. No published street consensus for the quarter was found. Alongside results the board approved a ~2% minority stake in premium antibiotic-free D2C brand Sids Farm (FY26 turnover ₹240 Cr) for ₹11.65 Cr cash from internal accruals — immaterial to financials but consistent with the stated 'selective acquisitions' stance and a foothold in premium/D2C dairy. The earnings call is set for 27 July 2026.
W1
Milk procurement cost trajectory — cost of materials at ₹940.6 Cr (+32% YoY); management's guided 50-100 bps FY27 gross-margin recovery now directly in question
W2
Standalone India margin repair — standalone PAT down to ₹21.75 Cr; whether pricing actions restore the 6%+ NPM in coming quarters
W3
HR Food Processing contribution as the YoY base normalizes from Q2 FY27, when consolidated growth stops being flattered by the acquisition
Clean digital PDF; consolidated PAT ₹40.64 Cr fully attributable to shareholders (NCI nil). No exceptional items this quarter (Q4 FY26 had ₹3.21 Cr consol / ₹3.28 Cr standalone). Note 8: results not YoY-comparable due to HR Food Processing consolidation (eff. 1 Aug 2025). Company changed rounding to crores from millions this quarter. Standalone (-65% YoY PAT) and consolidated (-35%) diverge sharply.
Record revenue, profit collapse: the pricing lag that defines the quarter
Dodla's highest-ever revenue of ₹1,198 Cr masks a structural margin squeeze: PAT collapsed 35% YoY and EBITDA margin fell 280 basis points, driven by procurement cost inflation that management has only partially passed through. The recovery case hinges entirely on price-through success in Q2+, but execution credibility is now in question.
₹1,198 Cr
Highest-ever; +19% YoY
₹41 Cr
-35% YoY
5.4%
vs 8.2% prior year; -280 bps
21.1L liters/day
+13% YoY (record)
Dodla's Q1 earnings deliver a paradox: the highest-ever quarterly revenue and record milk procurement, yet PAT crashed 35% year-on-year and EBITDA margin fell 280 basis points. The headline number conceals a structural problem — not a quarter to hang recovery hopes on without seeing evidence of it first.
Where the profit went
Milk procurement costs surged ₹3.9 per liter year-on-year to ₹41.3/L (driven by El-Niño weather and low flush-season milk supply), but Dodla's milk selling prices rose only ₹2.2 per liter to ₹59.4/L. That's a 56% pass-through rate — meaning management absorbed 44% of the cost inflation directly into margin. Gross margin compressed 260 basis points to 23.2%, and PAT margin fell 280 basis points to 5.4%. Management attributes this to seasonal/cyclical pressure and says the worst is behind. But the call reveals reactive pricing, not proactive. The ₹2/L milk hike and ₹1+ VAP increases were announced only on July 15 — well after Q1 close — suggesting the inflation wasn't fully priced in advance.
What management claimed vs. what holds up
"Margin pressure is cyclical; expect recovery Q2 onwards"
"Prices not fully passed; will gradually pass to consumers in forthcoming quarters"
"Highest-ever quarterly revenue of ₹1,198 crores, 19% YoY"
"India standalone milk procurement grew, ex-OSAM only 3%"
"VAP highest-ever sales of ₹415 crores, 17.6% growth; ex-bulk 40.6% growth"
"Africa delivered ₹154 crores revenue, 45.6% growth, EBITDA ₹24 crores up 74%"
The first claim — that this is cyclical — is overstated. A 280 basis point EBITDA miss against a 7–8% guidance target isn't seasonal noise; it's a structural execution gap. The second claim — gradual pass-through — is reality, but it came late. Revenue growth and VAP are solid. But India's core milk procurement grew only 3% ex-OSAM, a substantial deceleration from the 8–9% growth trajectory management had been guiding. Africa and VAP are carrying the growth story.
What changed on this call
Margin credibility weakened materially. The 7–8% EBITDA guidance for FY27 remains intact on the call, but management now explicitly pins recovery to Q2 onwards, admitting that Q1 fell short of internal expectations. This is a subtle but important shift: the guided recovery is now pushed out by one quarter, and will be measured against a new baseline (5.4%) rather than the prior-quarter expectation.
Core India growth decelerated. Analysts pressed hard on the 3% milk procurement growth ex-OSAM (Praveen Kumar, Equitas Capital, and others noted the slowdown from prior 8–9% guidance). Management's response: geographic selectivity. Dodla is not expanding aggressively in Tamil Nadu and Karnataka — regions with high cooperatives pricing gaps (₹10+ and ₹6–7 respectively) — because the risk-return doesn't work. Instead, it's focusing on Maharashtra (+10%) and geographic rotation into Bihar and eastern India. This is prudent, but it signals market maturity in core regions and acknowledges that price leadership has limits.
Africa and VAP remain the bright spots. Africa revenue reached ₹154 Cr (+45.6% YoY) with EBITDA of ₹24 Cr (+74%), and VAP (ex-bulk) grew 40.6%. Both delivered above consensus expectations and are driving the consolidated growth story. However, VAP's reported 17.6% growth masks a ₹57 Cr bulk sales exit (a one-time, non-repeatable decline). The cleaner metric is the 40.6% ex-bulk growth in lower-temperature logistics (LTL), which is sustainable but small in absolute magnitude.
The bull-bear ledger
Revenue +19% YoY, highest-ever ₹1,198 Cr; volume growth 13% in milk procurement
Africa scaled to ₹154 Cr with 45.6% growth and EBITDA now a ₹24 Cr contributor
VAP ex-bulk growing 40.6%, highest-ever ₹415 Cr sales; mix shift towards premium working
Balance sheet net debt-free with ₹689 Cr cash, funding ₹590 Cr capex without leverage
Price hikes initiated from July 15; management plans ₹2–2.5% additional milk hikes in Q2 and 3–4% VAP hikes
PAT crashed 35% YoY to ₹41 Cr; EBITDA margin fell 280 bps to 5.4%, missing 7–8% guidance materially
Pricing lag: only 56% of procurement cost inflation passed through; 44% absorbed into margin
Core India milk procurement only 3% growth ex-OSAM; market saturation and geographic constraints acknowledged
Margin recovery depends entirely on Q2+ price pass-through success; if elasticity kicks in or competitors slow to follow, volume growth at risk
Management credibility on guidance weakened by 280 bps EBITDA miss and reactive (not proactive) pricing response
Risks, ranked by holder impact
Pricing power erosion if competitors follow milk price hikes selectively
HighDodla's 4–5% FY27 pass-through plan assumes consumers will accept price hikes without volume elasticity. But Amul and Mother Dairy are lagging in the North and are cooperatives-subsidized in many regions. If they take hikes late or selectively, Dodla's volume growth (targeting 8–10%) could compress to low-single digits.
Procurement cost persistence if monsoon disruption continues
HighManagement assumes normalization to ₹41/L (already high vs historical), but May–June–July prices were all flat around ₹41.20/L with no seasonal relief yet. If El-Niño impacts extend, milk supply stays tight, and costs remain elevated, the 7–8% EBITDA recovery guidance will miss again in Q2, eroding credibility further.
Core India growth deceleration becoming structural, not cyclical
Medium3% milk growth ex-OSAM is material slowdown from 8–9%. Geographic rotation into lower-competitive areas (Bihar, eastern India) takes time to scale and may not offset saturation in core regions (TN, KA). If India's contribution continues to fade, consolidated growth depends increasingly on Africa and VAP, which are smaller bases.
Margin miss credibility: if Q2 EBITDA margin doesn't return to 7–8% range, guidance framework collapses
HighA second consecutive miss (after 280 bps miss in Q1) will signal that management's macro assumptions (procurement normalization, seasonal tailwinds, gradual price pass) are unreliable. Investors will demand a lower guidance range, compressing valuation multiples.
Working capital pressure if procurement costs stay elevated and inventory builds
LowIf milk supply remains muted (weak flush season) and company needs to hold inventory at high procurement costs, or become a net buyer, working capital strains emerge. However, ₹689 Cr cash and very short DSO (1.5–2 days) provide substantial buffer.
OSAM profitability stalling if cost pass-through fails in value-added segment
MediumOSAM is experiencing raw material inflation similar to core business. If its own margin squeeze persists, the acquisition (₹250 Cr goodwill amortization in P&L) becomes a profit drag rather than an earnings accretor. At present, profitability improving but far from normalized.
How the street is positioned (and what it's saying)
Price action tells a clear story of disappointment. Dodla closed at ₹1042 as of July 31, and the day-1 post-result reaction was a 3.64% decline (from a pre-result close of ₹1070). The sell-off has held: by day 5, the stock was down 2.62% from the pre-result close. This is not a knee-jerk dip that faded on buybacks or short-covering; it's a considered repricing downward as the street digested the 35% PAT decline and 280 bps EBITDA miss.
Valuation context: The stock is now trading at ₹1042, down 23.94% from its all-time high of ₹1370 and below its 20-day, 50-day, and 200-day moving averages (₹1083.43, ₹1092.28, ₹1145.84 respectively). The RSI is neutral at 34.1 — not oversold, but not showing strength. Volume is increasing on the decline, consistent with institutional unwinding.
Institutional flows show a divergence: Foreign institutional investors (FII) are in retreat: ownership fell from 10.03% in Q1 FY-2026 to 6.43% in Q4 FY-2026 — a 357 basis point decline. Conversely, domestic institutional investors (DII) are adding: ownership rose from 19.21% to 25.34% — a 613 basis point increase. This pattern — FII exit, DII add — suggests foreign investors are rotating out of the story (likely citing margin miss and margin recovery uncertainty), while domestic buyers are accumulating at lower prices (possibly on a belief that the 7–8% guidance is attainable). Promoter ownership remains stable at ~59%, showing no insider selling pressure near the highs.
In sum: the street's verdict (price action + flows) aligns with the fundamental read — cautious skepticism on the margin recovery story, but not panic-selling. The 23.94% drawdown from ATH is material, but not capitulation. This is an opportunity repricing, conditional on Q2 execution.
The debate
1 · Q2 FY-2027 price hike execution and volume resilience
Management plans ₹2–2.5% milk and 3–4% VAP hikes in Q2. The pass-through test is whether demand elasticity emerges (volume growth stays 8–10%) or whether consumers trim purchases. This quarter resolves the bull-bear debate.
2 · Procurement cost stabilization
May–June–July prices were flat at ₹41.20/L; no seasonal relief yet. Normalization assumption is that costs stay at elevated ₹41/L (not decline). If monsoon impacts persist, cost stays high, margin recovery is pushed further out.
3 · Competitive pricing response from Amul and Mother Dairy
So far they're lagging Dodla's hikes (TN gap ₹10+, KA gap ₹6–7 persist). If they accelerate price matching in H2, Dodla's margins benefit (industry-wide pass-through). If they stay selective or subsidized, Dodla's pricing power is limited and volume risk rises.
4 · Core India DDL growth stabilization
3% growth is below guidance. If Maharashtra ramp and geographic rotation into Bihar show lift in H1 results, the deceleration narrative reverses. If core India stays stuck in low-single digits, consolidated growth depends entirely on Africa and VAP (smaller bases).
5 · EBITDA margin trajectory in Q2 FY-2027
The single most important number. If EBITDA margin returns to 7–8% range, credibility is restored and the stock re-rates higher. If it stays below 6.5%, guidance collapses and multiples compress further.
The number to track from here
Dodla Dairy is in the middle of a critical test: can it pass through procurement cost inflation without losing volumes? Q1 showed only a 56% pass-through, well behind the 100% needed to protect margins. The call reassured that price hikes are underway and recovery is imminent — but execution gap is evident, and the street has repriced the stock down 23.94% from its high.
This is not a collapse-and-recovery story (yet). Revenue momentum is real, Africa is working, and the balance sheet is fortress-like. But profit resilience is in question, and guidance credibility has taken a hit. Earnings are steady-state, not step-change — and the single number that matters from Q2 onwards is EBITDA margin. If it recovers to 7–8%, the drawdown becomes a buying opportunity. If it stays compressed, the recovery narrative is broken, and multiples will settle lower.
Hold, but monitor Q2 price pass-through and margin recovery closely. The next quarter is the truth test.
Revenue growth masks 35% PAT collapse; margin recovery depends on price-pass timing
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit Q1 revenue target (19% vs 19% delivered), but missed EBITDA margin guide (5.4% actual vs 7-8% target). Margin miss is material (280 bps). Price hikes initiated July 15 were reactive, not proactive.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong volume and revenue growth (+19% YoY, record ₹1,198 Cr) masks a structural margin collapse: PAT crashed 35% YoY to ₹41 Cr, EBITDA margin fell 280 bps to 5.4% vs 8.2% prior year. Management attributes this to temporary procurement inflation and gradual pricing—but the real issue is execution lag: procurement costs rose ₹3.9/liter YoY while milk prices only rose ₹2.2/liter, a 44% shortfall. Margin recovery depends entirely on successful price pass-through from Q2 onwards, which remains unproven as of call date (late July).
₹1198 Cr
Revenue · +19% YoY₹41 Cr
Reported PAT · −35.4% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Margin pressure is cyclical, expect recovery Q2 onwards
OVERSTATEDEBITDA margin collapsed to 5.4% vs 8.2% a year ago; 280 bps decline. Q1 YoY PAT fell 35.4%
Prices not fully passed, will gradually pass to consumers in forthcoming quarters
MISSMilk sales price only rose ₹2.2/liter YoY despite ₹3.9/liter procurement cost hike. Pricing lagged 44% of cost inflation
Highest-ever quarterly revenue of ₹1,198 crores, 19% YoY
METDelivered ₹1,197.9 Cr, 19.0% YoY growth confirmed
India standalone milk procurement grew (ex-OSAM only 3%)
METAnalysts pressed hard: India DDL only 3% volume growth vs prior 8-9%. Africa & Maharashtra drove blended 13% growth
VAP highest-ever sales of ₹415 crores, 17.6% growth; ex-bulk 40.6% growth
METConfirmed ₹414.7 crores VAP ex-bulk, 40.6% LTL growth supported
Africa delivered ₹154 crores revenue, 45.6% growth, EBITDA ₹24 crores up 74%
METCall confirms both revenue and EBITDA figures and growth rates
Earnings quality
What changed since the last call
EBITDA margin guidance credibility
DowngradePrior 7-8% target; Q1 delivered 5.4%. Management now says recovery from Q2. Guidance track record weakened by 280 bps miss
India standalone growth trajectory
DowngradeCore India DDL procurement only 3% YoY (ex-OSAM). Prior implied 8-10%. Slowdown driven by pricing strategy (not expanding in high-price geographies like Andhra)
Margin recovery timeline
NeutralStill expect 7-8% by EoFY27, but now emphasize gradual pass-through from Q2. Q1 miss pushed recovery date out by 1 quarter
Africa & VAP outlook
UpgradeProcurement network quality
NeutralEmphasize Maharashtra +10%, but India overall 3% and selective growth (not expanding in Andhra due to competitive pricing). Supplier relationships strong but geog expansion cautious
The Q&A
Analysts pressed hard on three fronts: (1) Core India growth slowdown (Praveen Kumar, ICICI, others noted only 3% ex-OSAM vs prior 8-9%); (2) Timing of margin recovery (Aniruddha Joshi asked 'is worst behind?', management hedged); (3) Procurement data clarity (analyst forced management to break down OSAM, Africa, India separately; revealed India nearly flat). Management held up on Africa growth & VAP, but conceded pricing lagged cost inflation. Tone defensive but not evasive.
Margin trajectory — Praveen Kumar, Equitas Capital
PartialConfident 7-8% EBITDA maintained despite cyclical pressure; seasonal, not structural reset. Price pass-through underway
Procurement growth ex-OSAM — Praveen Kumar, Equitas Capital
AnsweredAndhra, Karnataka maintained (not degrowthing) but not expanding due to high competitive pricing; strategy is selective. Maharashtra +10%, Africa +28%
Margin recovery credibility — Aniruddha Joshi, ICICI Securities
PartialAfrica & Orga done 70-80% already. Dodla still catching up; took ₹1+ hike in May, ₹2 more in July, plan 2.5% in Q2. Most corrections done
Ice cream capex appetite — Aniruddha Joshi, ICICI Securities
AnsweredNo major expansion planned; growing from ₹16 Cr to ₹22 Cr Q1 on existing capacity. Wait & see this year; plan later
Milk price hike quantum — Darshita Shah, DSP Asset Managers
AnsweredPlan 2-2.5% more in Q2, targeting 4-5% for full year on milk. Blended (VAP) will be higher
Volume growth resilience — Darshita Shah, DSP Asset Managers
AnsweredYes, target maintained 8-10% volume growth; pricing passed gradually, so growth continues
Competitive pricing landscape — Yash Goenka, Awriga Capital
AnsweredAmul, Nandini taken ghee/milk hikes. National cooperatives will follow. TN gap ₹10+, KA gap ₹6-7. We took ₹2 avg across regions
Procurement cost normalization — Abhishek Mathur, Systematix Group
PartialNormalization = no decline expected, just stabilization at ₹41/liter. May-June-July all flat around ₹41.20. No seasonal drop yet
Milk sales volume slowdown — Aditya, Securities Investment Management
PartialSummer months, milk demand lower (shift to VAP). Africa milk +33% YoY. India milk 10.4L (seasonal). Normal trend resuming Q2
Execution priorities Q2+ — Sucrit Patil, EyeSight Fintrade
PartialAfrica on track to hit 100% targets (volume & EBITDA). Feed 25%+ growth. DDL already corrected pricing from mid-July. El-Niño weather impact, but no structural inventory issue
Portfolio composition 3-year outlook — Abhishek Kanithi, Nivaka Ventures
AnsweredAfrica stays ~10% (won't surge further without acquisitions). VAP: maintain 10% volume growth targeting; DDL 70-80%, overseas 15%, OSAM 8-10%
India core market growth headwinds — Bhavesh Jain, DD Investment Advisors
AnsweredCore markets: maintain share, not push given high cooperatives gaps (TN, KA). Maharashtra milk balancing only 2L local sales. Geographic rotation strategy. 10% blended target
Direct farmer payment & productivity — Manish Jain, GormalOne LLP
Answered100% direct farmer payment (nearly). Animal data hard to track; farmer avg increasing steadily. Dodla feed users do 14L vs non-users 11L per farmer
Guidance
FY27 consolidated 15% revenue growth (10% volume + 5% pricing/mix)
MediumAssumes continued India momentum + Africa scaling. Price hikes 4-5% target achievable but dependent on competitive landscape & demand elasticity
EBITDA 7-8% range FY27; recovery from Q2 onwards after Q1 cyclical 5.4%
MediumGradual pass-through of ₹2-2.5% milk + 3-4% VAP hikes Q2-Q3 expected to recover margin. Assumes procurement stabilizes at current ₹41/L
₹590 Cr capex (Maharashtra Greenfield, OSAM scale, Africa expansion) funded from internal accruals
HighNo leverage needed; ₹689 Cr cash sufficient. Maharashtra on timeline, Kenya utilization ramping 80%, Uganda full capacity planned Greenfield
Risks the call surfaced
Pricing power erosion
MediumDodla's ₹10+ price gap in TN, ₹6-7 in KA vs cooperatives will narrow if Amul/Mother Dairy take hikes. Current 4-5% FY27 hike plan may face volume pushback
Procurement cost persistence
HighMilk procurement costs elevated at ₹41.3/L vs ₹37.4/L prior year. Management expects normalization but says May-June-July all flat ~₹41.20/L. If monsoon disruption continues, prices stay high, margin recovery delayed
Core India DDL growth stalling
MediumIndia DDL standalone milk procurement only 3% YoY (ex-OSAM). Analysts noted growth has slowed from prior 8-9%. Geographic expansion constrained by high cooperatives pricing (TN, KA) and selective capacity strategy
Margin miss credibility
HighQ1 EBITDA margin 5.4% vs 7-8% prior guidance (280 bps miss). Management blamed cyclical/seasonal pressure and pricing lag, but recovery now pushed to Q2+. If Q2 misses again, credibility erodes; investor sentiment on margin recovery guidance would deteriorate
Working capital inventory risk
LowIf procurement costs stay elevated and milk supply remains muted (not flushing), company may need to build inventory or become net buyer at high prices, stressing working capital. However, ₹689 Cr cash provides buffer
Management
Score 6/10. Transparent on numbers but narrative tries to minimize margin miss. Admitted pricing lag but framed as strategy (gradual pass-through vs lump-sum hikes). Candid on geographic constraints (high pricing in TN/KA limits expansion). Some NDA shielding on Sids Farm investment rationale (vague 'learning' language) Mixed. Hit revenue growth targets (+19% YoY on track for 15% guidance) but MISSED EBITDA margin target materially (5.4% vs 7-8%, 280 bps shortfall). Pricing lag relative to procurement inflation (₹2.2 vs ₹3.9 hike) indicates reactive vs proactive execution. However, Africa & VAP delivering well
1 · Q2 FY27 (Aug-Sep)
Price hike pass-through completion; procurement cost normalization post-monsoon
2 · Q2 FY27 onwards
Maharashtra Greenfield capex ramp; East India capacity/Chandel production shift
3 · H2 FY27
OSAM profitability inflection; Kenya processing capacity utilization towards 100%
Margin recovery depends entirely on successful price pass-through from Q2 onwards, which remains unproven as of call date (late July).